Yale Offers New Medication for Fatal Disease
Yale Medicine physicians were the first in Connecticut to offer a new medication for hereditary transthyretin-mediated amyloidosis (hATTR), a life-threatening genetic mutation that causes transport proteins called transthyretin to cluster together and deposit amyloids in the peripheral nerves, heart, kidney, and gastrointestinal tract.
NIH Grants Fund Image-Guided Therapy After a Heart Attack
A team of researchers from the Yale School of Medicine and the University of Washington will use ultrasound to guide the delivery of theranostic hydrogels into the heart to prevent dilation of the heart post-MI and subsequent heart failure.
New Consensus for Managing Patients Hospitalized with Heart Failure
The American Heart Association estimates that by 2030 more than 8 million Americans will be diagnosed with chronic heart failure (HF). This condition may lead to kidney failure, liver damage, and other complications. The 2019 American College of Cardiology report provides clinical tools to improve the management of HF patients.
Blood Pressure Control Less Likely Among Those Treated in Low-income Areas
People enrolled in a large clinical hypertension management trial were half as likely to control their blood pressure if they received care at clinics and primary care practices in low-income areas, according to new Yale-led research.
Gene Plays Role in Early-Onset Heart Disease and Diabetes
When heart disease affects people under age 50, it’s considered “early onset” and experts believe there’s a genetic link. Yale investigators have found that a particular gene is common to families with multiple members who either have early-onset heart disease or are at risk for it.
TAVR Is Helping People Avoid Open Heart Surgery
Use of TAVR means patients spend fewer days in the hospital and are able to return to their normal lives far more quickly. Yale Medicine is expected to do 300 of the procedures this year at Bridgeport and Yale New Haven hospitals, and Yale cardiologists have been at the forefront of TAVR research in general since the procedure became available in the mid-2000s.
Meet Yale Internal Medicine Q&A with Daniel Jacoby, MD, Associate Professor and Director of the Cardiomyopathy Program and the Comprehensive Heart Failure Program
As part of our “Meet Yale Internal Medicine” series, today we are featuring Daniel Jacoby, MD, associate professor and director of the Cardiomyopathy Program and the Comprehensive Heart Failure Program.
Yale PET Scientists receive Early Career Investigator travel awards for 2019 BRAIN PET Meeting
Takuya Toyonaga, Xiaotian Fang, and Pragalath Sadasivam were awarded Early Career Investigator travel awards by the International Society for Cerebral Blood Flow & Metabolism (ISCBFM) to attend the BRAIN & BRAIN PET conference in Yokohama, Japan.
Professor of Surgery Receives Greece's Highest Academic Honor
John Elefteriades, MD, the William W.L. Glenn Professor of Surgery (Cardiac Surgery) and director of the Aortic Institute, has been inducted into the highly select Athens Academy, which draws its inspiration from Plato’s Academy and represents the highest academic honor bestowed by Greece for accomplishment in any scholarly discipline.